Skip to main content
HCPCS J0878 · Level II · Part B drug

J0878: daptomycin, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0878

Billing unit
1 MG
Daptomycin injection
ASP payment limit
$0.027
October 2026; -6.9% vs July 2026
Practitioner MUE
1000
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0878 is the Level II code for Injection, daptomycin, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.027 per billing unit, down 6.9% from July 2026. The practitioner MUE allows up to 1000 units per date of service (MAI 3), so a full 1000-unit day is $27.00 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names daptomycin: J0877 (the Hospira product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0878); J0874 (the Baxter product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0878); J0873 (the Xellia product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0878 or J0872); J0872 (the Xellia product (manufacturer named in its CMS descriptor); unrefrigerated; not therapeutically equivalent to J0878 or J0873); J0871 (the Endo product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0878). The ASP crosswalk maps 33 NDCs to it, sold as Daptomycin by Hikma Pharmaceuticals USA Inc., Northstar RxLLC, Accord Healthcare Inc. No current Billing and Coding Article lists J0878, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0878 at $0.027 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.029 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0878
QuarterPayment limitPerCoinsurance
October 2026$0.0271 MG20%
July 2026$0.0291 MG—
CMS note: AMP-based payment limit

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 33 NDCs from 14 labelers to J0878. Report the NDC in the claim's drug segment and bill the number of J0878 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J0878
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9378-01DaptomycinHikma Pharmaceuticals USA Inc.1 × 1500
00143-9444-01DaptomycinHikma Pharmaceuticals USA Inc.1 × 1500
00143-9465-01DaptomycinHikma Pharmaceuticals USA Inc.1 × 1500
16714-0892-01DaptomycinNorthstar RxLLC1 × 1500
16729-0434-05DaptomycinAccord Healthcare Inc1 × 1350
16729-0434-45DaptomycinAccord Healthcare Inc1 × 103500
16729-0435-05DaptomycinAccord Healthcare Inc1 × 1500
25021-0174-15DaptomycinSagent Pharmaceuticals1 × 1500
25021-0174-16DaptomycinSagent Pharmaceuticals1 × 105000
25021-0179-15DaptomycinSagent Pharmaceuticals1 × 1350
25021-0179-16DaptomycinSagent Pharmaceuticals1 × 103500
25021-0179-66DaptomycinSagent Pharmaceuticals1 × 1350
25021-0179-67DaptomycinSagent Pharmaceuticals1 × 103500
43598-0413-11DaptomycinDr. Reddy's Laboratories Inc.1 × 1500
43598-0476-11DaptomycinDr. Reddy's Laboratories Inc.1 × 1350
55150-0344-01DaptomycinEugia US LLC1 × 1500
60505-6229-04DaptomycinApotex Corp1 × 1500
67457-0813-50DaptomycinMylan Institutional LLC1 × 1500
67457-0941-15DaptomycinMylan Institutional LLC1 × 1500
68001-0376-68DaptomycinBluePoint Laboratories1 × 1500
70377-0093-91DaptomycinBiocon Pharma Inc1 × 1500
70594-0034-01DaptomycinXellia Pharmaceuticals USA, LLC.1 × 1500
70594-0034-02DaptomycinXellia Pharmaceuticals USA, LLC.1 × 1500
71288-0016-15DaptomycinMeitheal Pharmaceuticals Inc.1 × 1500
71288-0016-91DaptomycinMeitheal Pharmaceuticals Inc.1 × 1500
71288-0016-95DaptomycinMeitheal Pharmaceuticals Inc.1 × 1500
71288-0017-15DaptomycinMeitheal Pharmaceuticals Inc.1 × 1350
71288-0017-91DaptomycinMeitheal Pharmaceuticals Inc.1 × 1350
71839-0107-01DaptomycinBE Pharmaceuticals Inc.1 × 1500
71839-0108-01DaptomycinBE Pharmaceuticals Inc.1 × 1350
72572-0102-01DaptomycinCivica, Inc.1 × 1500
72603-0147-01DaptomycinNorthstar RxLLC1 × 1350
72603-0152-01DaptomycinNorthstar RxLLC1 × 1500

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0878. For practitioners the limit is 1000 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0878 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services10003 Date of Service Edit: ClinicalCMS Policy
Facility outpatient hospital10003 Date of Service Edit: ClinicalCMS Policy
DME supplier10003 Date of Service Edit: ClinicalCMS Policy

MUE for J0878 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0878 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0878 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0878 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0878 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0878 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0878 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0878 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0878

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0878

What does HCPCS code J0878 describe?

J0878 is defined by CMS as "Injection, daptomycin, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0878 a CPT code?

No. J0878 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as daptomycin; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0878 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0878 in October 2026?

The ASP-based payment limit is $0.027 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.029. Commercial payers use their own fee schedules.

How many units of J0878 can be billed per day?

The practitioner Medically Unlikely Edit is 1000 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "CMS Policy" as the rationale.

Which NDCs map to J0878?

The October 2026 ASP crosswalk lists 33 NDCs from 14 labelers: Daptomycin (Hikma Pharmaceuticals USA Inc.); Daptomycin (Northstar RxLLC); Daptomycin (Accord Healthcare Inc); Daptomycin (Sagent Pharmaceuticals). For example NDC 00143-9378-01 (package size 1) equals 500 billing units of J0878.

Does J0878 have NCCI bundling edits?

No active practitioner PTP pairs list J0878 as a column-1 or column-2 code in the v323r0 release.

J0878 vs J0877: what is the difference?

Both are HCPCS Level II codes whose descriptor names daptomycin. What sets J0877 apart: the Hospira product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0878. J0878 is billed per 1 mg, limit $0.027, MUE 1000; J0877 is billed per 1 mg, limit $0.022, MUE 1000. Report the code whose descriptor matches the product and setting in the record.

J0878 vs J0874: what is the difference?

Both are HCPCS Level II codes whose descriptor names daptomycin. What sets J0874 apart: the Baxter product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0878. J0878 is billed per 1 mg, limit $0.027, MUE 1000; J0874 is billed per 1 mg, limit $0.062, MUE 1000. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.